• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与肝肾微粒体抗体相关的肝脏疾病

Hepatic disorders associated with liver-kidney microsomal antibodies.

作者信息

Smith M G, Williams R, Walker G, Rizzetto M, Doniach D

出版信息

Br Med J. 1974 Apr 13;2(5910):80-4. doi: 10.1136/bmj.2.5910.80.

DOI:10.1136/bmj.2.5910.80
PMID:4596402
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1610709/
Abstract

A study of the clinical associations of a recently defined tissue autoantibody, the liver/kidney microsomal (L.K.M.) antibody, showed that out of 33 patients 26 had clinical liver disease. Fifteen of the patients had active chronic hepatitis and there were seven cases of acute hepatitis, precipitated by presumed virus A infection in three instances and by drug hypersensitivity in the other four. The remaining cases with liver disease included two with subclinical hepatitis and two with hepatocellular carcinoma. Evidence is presented that the patients with active chronic hepatitis may represent a distinct subgroup of the disease with a young mean age, an even male to female ratio, and a striking lack of other nonorgan-specific autoantibodies-that is, antinuclear and smooth muscle-which are usually present in the other autoimmune variant of the disease.

摘要

一项针对最近定义的组织自身抗体——肝/肾微粒体(L.K.M.)抗体的临床关联研究表明,在33例患者中,26例患有临床肝病。其中15例为活动性慢性肝炎,7例为急性肝炎,3例急性肝炎由推测的甲型病毒感染诱发,另外4例由药物过敏引起。其余肝病病例包括2例亚临床肝炎和2例肝细胞癌。有证据表明,活动性慢性肝炎患者可能代表该疾病的一个独特亚组,其平均年龄较轻,男女比例均衡,且明显缺乏其他非器官特异性自身抗体,即抗核抗体和平滑肌抗体,而这些抗体通常存在于该疾病的其他自身免疫变体中。

相似文献

1
Hepatic disorders associated with liver-kidney microsomal antibodies.与肝肾微粒体抗体相关的肝脏疾病
Br Med J. 1974 Apr 13;2(5910):80-4. doi: 10.1136/bmj.2.5910.80.
2
A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.慢性丙型肝炎患者与自身免疫性肝炎患者自身抗体患病率的比较:干扰素在自身免疫性疾病发生中的作用。
Hepatogastroenterology. 1997 Mar-Apr;44(14):417-25.
3
Hepatitis C virus-related chronic liver disease with autoantibodies to liver-kidney microsomes (LKM). Clinical characterization from idiopathic LKM-positive disorders.丙型肝炎病毒相关的慢性肝病伴抗肝肾微粒体(LKM)自身抗体。与特发性LKM阳性疾病的临床特征比较。
J Hepatol. 1991 Jul;13(1):128-31. doi: 10.1016/0168-8278(91)90874-b.
4
Laboratory tests for diagnosis of autoimmune diseases.用于自身免疫性疾病诊断的实验室检测。
Prog Clin Pathol. 1975;6:177-203.
5
Non-organ specific autoantibodies associated with chronic C virus hepatitis.与慢性丙型肝炎相关的非器官特异性自身抗体。
J Hepatol. 1993 Jul;18(3):359-64. doi: 10.1016/s0168-8278(05)80281-8.
6
Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1.特发性自身免疫性肝炎中肝肾微粒体自身抗体的主要抗原是细胞色素P450db1。
J Clin Invest. 1989 Mar;83(3):1066-72. doi: 10.1172/JCI113949.
7
A new anti-liver-kidney microsome antibody (anti-LKM2) in tienilic acid-induced hepatitis.替尼酸诱导的肝炎中一种新的抗肝肾微粒体抗体(抗-LKM2)
Clin Exp Immunol. 1984 Mar;55(3):561-70.
8
[Tienilic acid-induced hepatitis associated with liver/kidney microsomal antibody (author's transl)].
Nouv Presse Med. 1980 Jun 21;9(27):1881-4.
9
Characterization of anti-liver kidney microsomal antibody in childhood autoimmune chronic active hepatitis: evidence for IgG1 subclass restriction, polyclonality and non cross-reactivity with hepatocyte surface antigens.儿童自身免疫性慢性活动性肝炎中抗肝肾微粒体抗体的特征:IgG1亚类限制、多克隆性及与肝细胞表面抗原无交叉反应的证据
Clin Exp Immunol. 1987 Sep;69(3):543-9.
10
[Prevalence of circulating autoantibodies in healthy individuals].[健康个体中循环自身抗体的患病率]
Med Klin (Munich). 2002 Nov 15;97(11):645-9. doi: 10.1007/s00063-002-1207-z.

引用本文的文献

1
Liver functions in silica-exposed workers in Egypt: possible role of matrix remodeling and immunological factors.埃及接触二氧化硅工人的肝功能:基质重塑和免疫因素的可能作用。
Int J Occup Environ Health. 2014 Apr-Jun;20(2):146-56. doi: 10.1179/2049396714Y.0000000061. Epub 2014 Mar 24.
2
Autoimmune hepatitis as a unique form of an autoimmune liver disease: immunological aspects and clinical overview.自身免疫性肝炎作为自身免疫性肝病的一种独特形式:免疫学方面及临床概述
Autoimmune Dis. 2012;2012:312817. doi: 10.1155/2012/312817. Epub 2012 Dec 12.
3
Autoimmune liver serology: current diagnostic and clinical challenges.自身免疫性肝病血清学:当前的诊断及临床挑战
World J Gastroenterol. 2008 Jun 7;14(21):3374-87. doi: 10.3748/wjg.14.3374.
4
Detection of liver kidney microsomal type 1 antibody using molecularly based immunoassays.使用基于分子的免疫测定法检测肝肾微粒体1型抗体。
J Clin Pathol. 2002 Dec;55(12):906-9. doi: 10.1136/jcp.55.12.906.
5
Autoantibodies to human cytosol: a marker of sporadic porphyria cutanea tarda.针对人细胞质的自身抗体:迟发性皮肤卟啉症散发型的一个标志物。
Clin Exp Immunol. 2001 Oct;126(1):47-53. doi: 10.1046/j.1365-2249.2001.01645.x.
6
Chronic hepatitis C associated with anti-liver/kidney microsome-1 antibody is not a subgroup of autoimmune hepatitis.与抗肝肾微粒体-1抗体相关的慢性丙型肝炎并非自身免疫性肝炎的一个亚组。
J Gastroenterol. 1997 Dec;32(6):769-76. doi: 10.1007/BF02936953.
7
Differences in immune recognition of cytochrome P4502D6 by liver kidney microsomal (LKM) antibody in autoimmune hepatitis and chronic hepatitis C virus infection.自身免疫性肝炎和慢性丙型肝炎病毒感染中,肝肾微粒体(LKM)抗体对细胞色素P4502D6免疫识别的差异。
Clin Exp Immunol. 1994 Jul;97(1):94-9. doi: 10.1111/j.1365-2249.1994.tb06585.x.
8
HBsAg-induced hypertrophic smooth endoplasmic reticulum as a target for liver-kidney microsomal (LKM) antibodies.乙肝表面抗原诱导的肥大滑面内质网作为肝肾微粒体(LKM)抗体的靶标。
Clin Exp Immunol. 1981 Mar;43(3):599-604.
9
Liver cell surface expression of the antigen reacting with liver-kidney microsomal antibody (LKM).与肝肾微粒体抗体(LKM)发生反应的抗原在肝细胞表面的表达。
Clin Exp Immunol. 1984 Jan;55(1):36-40.
10
Detection of liver-kidney microsomal autoantibodies by radioimmunoassay and their relation to anti-mitochondrial antibodies in inflammatory liver diseases.采用放射免疫分析法检测肝肾微粒体自身抗体及其在炎症性肝病中与抗线粒体抗体的关系。
Clin Exp Immunol. 1984 Sep;57(3):600-8.

本文引用的文献

1
SEROLOGICAL TESTS IN DIAGNOSIS OF PRIMARY BILIARY CIRRHOSIS.原发性胆汁性肝硬化诊断中的血清学检测
Lancet. 1965 Apr 17;1(7390):827-31. doi: 10.1016/s0140-6736(65)91372-3.
2
Mitochondrial antibodies in primary biliary cirrhosis. 3. Characterization of the inner-membrane complement fixing antigen.原发性胆汁性肝硬化中的线粒体抗体。3. 内膜补体结合抗原的特性
Clin Exp Immunol. 1969 May;4(5):511-25.
3
Mitochondrial and other tissue autoantibodies in patients with biological false positive reactions for syphilis.梅毒生物学假阳性反应患者的线粒体及其他组织自身抗体
Clin Exp Immunol. 1970 Jun;6(6):871-84.
4
Laxative-induced chronic liver disease.
Scand J Gastroenterol. 1972;7(4):395-402. doi: 10.3109/00365527209180760.
5
Immunochemical quantitation of antigens by single radial immunodiffusion.通过单向辐射免疫扩散法对抗原进行免疫化学定量。
Immunochemistry. 1965 Sep;2(3):235-54. doi: 10.1016/0019-2791(65)90004-2.
6
Non-organ-specific cytoplasmic antibodies detected by immunofluorescence.通过免疫荧光检测到的非器官特异性细胞质抗体。
Int Arch Allergy Appl Immunol. 1971;41(4):501-13. doi: 10.1159/000230545.
7
Antimitochondrial antibodies in jaundice following drug administration.药物性黄疸中的抗线粒体抗体。
JAMA. 1969 Apr 7;208(1):148-50.
8
Microsomal antibodies in active chronic hepatitis and other disorders.活动性慢性肝炎及其他病症中的微粒体抗体。
Clin Exp Immunol. 1973 Nov;15(3):331-44.
9
The presentation and diagnosis of 100 patients with primary biliary cirrhosis.100例原发性胆汁性肝硬化患者的临床表现与诊断
N Engl J Med. 1973 Sep 27;289(13):674-8. doi: 10.1056/NEJM197309272891306.
10
Halothane hepatitis--fact or fallacy?氟烷性肝炎——事实还是谬误?
Proc R Soc Med. 1973 Jan;66(1 Pt 1):56-63. doi: 10.1177/00359157730661P130.